Top Stories for 3/26

AstraZeneca vaccine shows 79% efficacy in trials but is not without controversy; Everlywell acquires PWNHealth and subsidiary Home Access Health . Plus: U.S. Department of Veterans Affairs undertaking a strategic review of its Cerner electronic health record modernization program . Links to the stories: AstraZeneca vaccine shows 79% efficacy in phase III trial AstraZeneca is questioned over potential use of outdated information in its COVID-19 clinical trial Everlywell forms new at-home l...